Amgen’s focus on blood cell medications continued in the 2000s, with the approval of Aranesp for the treatment of anaemic patients with chronic renal failure, and the 2002 approval of Neulasta ...

First set up in the 1980s, the alliance led to former Amgen blockbusters like red blood cell stimulator Epogen (epoetin alfa) and Neulasta (filgrastim) for low white blood cell counts caused by ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

You may be able to make yourself pee with certain practices, including listening to running water or trying relaxation techniques. Have you ever wondered how your body knows when it’s time to ...

DiveWire guarantees visibility for your news announcements through instant distribution to BioPharma Dive’s audience and its 176,000 newsletter subscribers for 21 days.